Adcon-L is a pharmaceutical gel designed to reduce the incidence and severity of scarring in back operations.
It consists of a combination of marginally water-soluble artificial sugars, and is re-absorbed into the body within several months of application.
[1] Four randomized controlled trials of particular interest were done regarding Adcon-L's effect on scarring and clinical outcomes.
The first trial done determined that the adhesion reduced the severity of the scarring post-operation as well as have minor improvements in clinical outcomes.
Based on the first trial and the original study from the second, the gel reduces scars but no certain benefit in clinical outcome.